MPI is proud to announce a new podcast from our Leadership team member Dr. Roneet Lev. Dr. Roneet Lev, an emergency and addiction doctor who has served as the first Chief Medical Officer of the White House Office of National Drug Control Policy, ONDCP and still practices on the front lines.
On High Truths, you will learn from experts, hear stories from the emergency department, and listen to people who have struggled from addiction. On each episode, our experts will answer a question from You, our listeners.
The MPI recently recorded a webinar with the Partners in Prevention, Missouri's higher education substance misuse coalition. The webinar is part of a recently developed training series in partnership with the PTTC. Our presentation discusses data from the most recent MPI Impact Report, COVID-19 impacts, and future prevention recommendations.
There are five webinars on a variety of topics related to substance use prevention and they are all free, you just need to register to access the series. Registration information can be accessed here: https://www.mopiptraining.org/
Question Is prenatal exposure to cannabis associated with child outcomes?
Findings This cross-sectional analysis of 11 489 children (655 exposed to cannabis prenatally) found that prenatal cannabis exposure after maternal knowledge of pregnancy was associated with greater psychopathology during middle childhood, even after accounting for potentially confounding variables.
Meaning Prenatal cannabis exposure may increase risk for psychopathology; consistent with recent recommendations by the Surgeon General of the United States, these data suggest that cannabis use during pregnancy should be discouraged by clinicians and dispensaries.
Many people, he added, are reluctant to tell doctors they use the drug or that they are dependent on it. CHS remains “way underrecognized” by doctors, he said, and is a diagnosis of exclusion typically made after other conditions have been ruled out.
“CHS is a very frustrating and alienating condition to have,” Danovitch added. “It often takes people a long time to be diagnosed and there’s a lot of suffering along the way.”
Data collected in May shows that teenagers and young adults who vape face a much higher risk of COVID-19 than their peers who do not vape, Stanford researchers found.